The stock's overall trend over the past six months has been volatile, with a significant decline in October 2025 followed by a recovery and subsequent pullback. The price fell from around $104 in early October to a low near $80 by early November, before rallying to a recent high near $120 in late February 2026, and then retreating to its current level of $100.09. In the short term, the stock has underperformed, with a 1-month change of -14.65% and a 3-month change of -3.45%. This recent weakness contrasts with a strong performance earlier in the period, as evidenced by the sharp rally from January into February. The current price of $100.09 sits approximately 24.9% above its 52-week low of $78.91 and 25.0% below its 52-week high of $133.43, placing it in the lower-middle portion of its annual range. The stock's relative strength versus the S&P 500 has been negative over one month and one year.

Revenue and profitability remain strong. For the latest quarter (Q3 FY2026 ending Dec 31, 2025), revenue grew 7.14% year-over-year to $1.96 billion. The company maintains robust margins, with a gross margin of 59.84% and a net margin of 24.58% for the quarter, indicating healthy profitability. The company exhibits excellent financial health, with a low debt-to-equity ratio of 0.11 and a strong current ratio of 3.72. Free cash flow generation is substantial, with TTM free cash flow reported at $929.1 million, providing ample liquidity for operations and shareholder returns like share repurchases. Operational efficiency is high, as demonstrated by a trailing Return on Equity (ROE) of 38.44% and a Return on Assets (ROA) of 19.90%. These metrics indicate effective use of shareholder capital and company assets to generate profits.